Adjunct Faculty
Adjunct faculty typically have an academic or research appointment at another institution and contribute or collaborate with one or more School of Medicine faculty members or programs.
Adjunct rank detailsLaura Airas
Research
Publications
2026
The test-retest reproducibility of [11C]PK11195 positron emission tomography using Biograph Vision Quadra scanner
Sjöros T, Matilainen M, Saunavaara V, Wahlroos S, Rajander J, Koivumäki M, Honkonen E, Luoma A, Airas L. The test-retest reproducibility of [11C]PK11195 positron emission tomography using Biograph Vision Quadra scanner. EJNMMI Research 2026 PMID: 42230367, DOI: 10.1186/s13550-026-01460-6.Peer-Reviewed Original ResearchTSPO-PET-measurable neuroinflammation associates with information processing speed decline in multiple sclerosis.
Saraste M, Nikkilä T, Matilainen M, Hämäläinen P, Wahlroos S, Rajander J, Snellman A, Rinne J, Airas L. TSPO-PET-measurable neuroinflammation associates with information processing speed decline in multiple sclerosis. Multiple Sclerosis Journal 2026, 13524585261446839. PMID: 42218616, DOI: 10.1177/13524585261446839.Peer-Reviewed Original ResearchEfficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study
Giovannoni G, Airas L, Bove R, Cutter G, Czarnecki M, Drulovic J, Hobart J, Kuhle J, Montalban X, Selmaj K, Tur C, Wolinsky J, Baldinotti A, Bonati U, Craveiro L, Giacobino C, Manfrini M, Schneble H, Stevenson P, Wang Q, Yang K, Oh J, group O, Barnett M, Dwyer C, Macdonell R, Marriott M, Simpson M, Popescu V, Van Pesch V, Willekens B, Lilovski H, Milanov I, Tsvetanov P, Macdougall A, Marriott J, McKelvey J, Oh J, Thorne M, Vosoughi R, Navas C, Ruiz C, Habek M, Kes V, -Piskac S, Airas L, Castelnovo G, Clavelou P, De Seze J, Laplaud D, Mathey G, Ruet A, Beridze M, Janelidze M, Tsiskaridze A, Bergamaschi R, Comi G, Filippi M, Grimaldi L, Inglese M, Lus G, Malucchi S, Marfia G, Pozzilli C, Ristori G, Uccelli A, Abboud H, Mourad A, Farfan F, Meza E, Gurrola M, Martinez-Manzanera C, Rivas V, San Juan Orta D, Kissani N, Louhab N, Regragui W, Mason D, Mottershead J, Bartosik-Psujek H, Bonek R, Chyrchel-Paszkiewicz U, Czarnecki M, Fryze W, Jasinska E, Kulakowska A, Maciejowski M, Ochudło S, Ratajczak M, Rejdak K, Selmaj K, Slowik A, Stryczynska K, Susz-Kolodynska M, Swiat M, Tomaszewska M, Tutaj A, Zbrojkiewicz J, Zielinski T, Cerqueira J, Ferreira J, Martins A, Mendes I, Santos E, Vale J, Albu C, Balasa R, Ionescu A, Manescu S, Agafina A, Arefyeva E, Arzumanyan N, Belova A, Brylev L, Dorogov N, Evdoshenko E, Greshnova I, Khabirov F, Khachanova N, Kotov S, Parshina E, Prokopenko S, Sazonov D, Sherman M, Sivertseva S, Sokolova I, Trushnikova T, Volkova L, Zakharova M, Aleksic D, Dincic E, Drulovic J, Gavric-Kezic M, Krsmanovic Z, Smiljanic-Miljkovic D, Szakalas L, Toncev G, Rodriguez E, Arroyo R, Blanco Y, Costa-Frossard L, Madueño S, Montero Y, Estruch B, Montalban X, Merino A, Gonzalez I, Meca J, Sabin J, Hinarejos A, Kuhle J, Damak M, Frih-Ayed M, Gouider R, Mhiri C, Cherkez A, Daineka N, Gryb V, Halych L, Ignatenko I, Kalbus O, Kobys T, Korolova O, Kostiuchenko A, Kovalenko O, Moskovko G, Myronova O, Nehrych T, Neryanova Y, Novakovska O, Peleshok S, Sanotskyy Y, Seliuk O, Shulga O, Skrypchenko I, Smolanka V, Tomakh N, Yaholnyk V, Artal F, Chataway J, de Angelis F, Gallagher P, Giovannoni G, Gran B, Hobart J, Paling D, Pearson O, Sharaf N, Tallantyre E, Tur C, Webb S, Amjad F, Boster A, Bove R, Cutter G, Huang D, Jacobs D, Lynch S, Schneider J, Shafer S, Wolinsky J. Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study. The Lancet 2026, 407: 2195-2207. PMID: 42208561, DOI: 10.1016/s0140-6736(26)00617-3.Peer-Reviewed Original ResearchAssociation between post-COVID-19 neuropsychiatric symptoms and persistent glial activation in the limbic system: a TSPO PET study
Tuomaala J, Saraste M, Smith E, Kuusi M, Westerberg E, Honkonen E, Kargar R, Laaksonen S, Lehto J, Luoma A, Matilainen M, Misin O, Atosuo J, Kanerva M, Liira H, Laakso S, Posharina T, Saunavaara V, Wahlroos S, Rajander J, Airas L. Association between post-COVID-19 neuropsychiatric symptoms and persistent glial activation in the limbic system: a TSPO PET study. Journal Of Neurology 2026, 273: 298. PMID: 42059960, PMCID: PMC13132884, DOI: 10.1007/s00415-026-13842-w.Peer-Reviewed Original ResearchTSPO-PET-measurable neuroinflammation associates with brain atrophy in multiple sclerosis
Yenikekaluva A, Sjöros T, Matilainen M, Snellman A, Rinne J, Alfaifi B, Hinz R, Saraste M, Airas L. TSPO-PET-measurable neuroinflammation associates with brain atrophy in multiple sclerosis. Multiple Sclerosis And Related Disorders 2026, 110: 107207. PMID: 42025273, DOI: 10.1016/j.msard.2026.107207.Peer-Reviewed Original ResearchPET imaging of microglial pathology in multiple sclerosis
Hartiala O, Tuomaala J, Airas L. PET imaging of microglial pathology in multiple sclerosis. Current Opinion In Neurology 2026, 39: 240-246. PMID: 41947663, PMCID: PMC13152060, DOI: 10.1097/wco.0000000000001490.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsSV2A PET reveals synaptic density loss in experimental autoimmune encephalomyelitis and in a pilot multiple sclerosis study
Chia P, Toyonaga T, Tong J, Le H, Dias M, Boyle A, Raymond R, Longbrake E, Huang Y, Carson R, Airas L, Vasdev N, Chen M, Zheng C. SV2A PET reveals synaptic density loss in experimental autoimmune encephalomyelitis and in a pilot multiple sclerosis study. Proceedings Of The National Academy Of Sciences Of The United States Of America 2026, 123: e2517709123. PMID: 41774796, PMCID: PMC12974510, DOI: 10.1073/pnas.2517709123.Peer-Reviewed Original ResearchCorrection: Longitudinal accumulation of glial activation measured by TSPO-PET predicts later brain atrophy in multiple sclerosis
Nylund M, Lehto J, Matilainen M, Rajander J, Wahlroos S, Sucksdorff M, Kuhlmann T, Airas L. Correction: Longitudinal accumulation of glial activation measured by TSPO-PET predicts later brain atrophy in multiple sclerosis. Journal Of Neuroinflammation 2026, 23: 46. PMID: 41630005, PMCID: PMC12862898, DOI: 10.1186/s12974-026-03700-x.Commentaries, Editorials and LettersReal-world detection of paramagnetic rim lesions and their association with disease burden in multiple sclerosis
Misin O, Piispanen A, Matilainen M, Parkkola R, Nyman M, Sainio T, Hirvonen J, Airas L. Real-world detection of paramagnetic rim lesions and their association with disease burden in multiple sclerosis. Multiple Sclerosis And Related Disorders 2026, 107: 107012. PMID: 41564463, DOI: 10.1016/j.msard.2026.107012.Peer-Reviewed Original Research
2025
Toward a Neuroimaging Consensus for the Work-up of Adult Genetic Leukoencephalopathies on Behalf of the White Matter Rounds Network: State of Practice.
Wong A, Airas L, Alvarez E, Antel J, Araujo D, Bernard G, Boudjani H, Brais B, Cocozza S, Corboy J, Fadda G, Imitola J, Lacasse M, Longbrake E, Macaron G, Narayanan S, Orthmann-Murphy J, Ortiz J, Shor N, Uggetti C, Venkateswaran S, Wilson N, Miller E, La Piana R. Toward a Neuroimaging Consensus for the Work-up of Adult Genetic Leukoencephalopathies on Behalf of the White Matter Rounds Network: State of Practice. American Journal Of Neuroradiology 2025, 47: 1448-1455. PMID: 41371978, PMCID: PMC13232682, DOI: 10.3174/ajnr.a9127.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
Get In Touch
Contacts
Email